158 related articles for article (PubMed ID: 26046936)
21. Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation.
Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
Br J Pharmacol; 2012 Jun; 166(4):1433-43. PubMed ID: 22300296
[TBL] [Abstract][Full Text] [Related]
22. Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
Banke TG; Chaplan SR; Wickenden AD
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1457-68. PubMed ID: 20457836
[TBL] [Abstract][Full Text] [Related]
23. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
[TBL] [Abstract][Full Text] [Related]
24. (-)-α-Bisabolol reduces orofacial nociceptive behavior in rodents.
Melo LT; Duailibe MA; Pessoa LM; da Costa FN; Vieira-Neto AE; de Vasconcellos Abdon AP; Campos AR
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):187-195. PubMed ID: 27900410
[TBL] [Abstract][Full Text] [Related]
25. Activation of transient receptor potential ankyrin 1 evokes nociception through substance P release from primary sensory neurons.
Nakamura Y; Une Y; Miyano K; Abe H; Hisaoka K; Morioka N; Nakata Y
J Neurochem; 2012 Mar; 120(6):1036-47. PubMed ID: 22182301
[TBL] [Abstract][Full Text] [Related]
26. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
[TBL] [Abstract][Full Text] [Related]
27. Effects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels.
Oguri G; Nakajima T; Yamamoto Y; Takano N; Tanaka T; Kikuchi H; Morita T; Nakamura F; Yamasoba T; Komuro I
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(9):H1339-52. PubMed ID: 25172898
[TBL] [Abstract][Full Text] [Related]
28. TRPA1 is activated by direct addition of cysteine residues to the N-hydroxysuccinyl esters of acrylic and cinnamic acids.
Sadofsky LR; Boa AN; Maher SA; Birrell MA; Belvisi MG; Morice AH
Pharmacol Res; 2011 Jan; 63(1):30-6. PubMed ID: 21094256
[TBL] [Abstract][Full Text] [Related]
29. Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1.
Fusi C; Materazzi S; Benemei S; Coppi E; Trevisan G; Marone IM; Minocci D; De Logu F; Tuccinardi T; Di Tommaso MR; Susini T; Moneti G; Pieraccini G; Geppetti P; Nassini R
Nat Commun; 2014 Dec; 5():5736. PubMed ID: 25484020
[TBL] [Abstract][Full Text] [Related]
30. Etodolac blocks the allyl isothiocyanate-induced response in mouse sensory neurons by selective TRPA1 activation.
Inoue N; Ito S; Nogawa M; Tajima K; Kyoi T
Pharmacology; 2012; 90(1-2):47-54. PubMed ID: 22739568
[TBL] [Abstract][Full Text] [Related]
31. Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studies.
Sjögren E; Halldin MM; Stålberg O; Sundgren-Andersson AK
Eur J Pain; 2018 May; 22(5):889-903. PubMed ID: 29377430
[TBL] [Abstract][Full Text] [Related]
32. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
[TBL] [Abstract][Full Text] [Related]
33. Activation of TRPA1 by luminal stimuli induces EP4-mediated anion secretion in human and rat colon.
Kaji I; Yasuoka Y; Karaki S; Kuwahara A
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(7):G690-701. PubMed ID: 22207576
[TBL] [Abstract][Full Text] [Related]
34. Activation of transient receptor potential ankyrin-1 (TRPA1) in lung cells by wood smoke particulate material.
Shapiro D; Deering-Rice CE; Romero EG; Hughen RW; Light AR; Veranth JM; Reilly CA
Chem Res Toxicol; 2013 May; 26(5):750-8. PubMed ID: 23541125
[TBL] [Abstract][Full Text] [Related]
35. Functional expression of the transient receptor potential channel TRPA1, a sensor for toxic lung inhalants, in pulmonary epithelial cells.
Büch TR; Schäfer EA; Demmel MT; Boekhoff I; Thiermann H; Gudermann T; Steinritz D; Schmidt A
Chem Biol Interact; 2013 Dec; 206(3):462-71. PubMed ID: 23994502
[TBL] [Abstract][Full Text] [Related]
36. Etodolac activates and desensitizes transient receptor potential ankyrin 1.
Wang S; Dai Y; Kogure Y; Yamamoto S; Zhang W; Noguchi K
J Neurosci Res; 2013 Dec; 91(12):1591-8. PubMed ID: 24027177
[TBL] [Abstract][Full Text] [Related]
37. Spinal transient receptor potential ankyrin 1 channel induces mechanical hypersensitivity, increases cutaneous blood flow, and mediates the pronociceptive action of dynorphin A.
Wei H; Saarnilehto M; Falck L; Viisanen H; Lasierra M; Koivisto A; Pertovaara A
J Physiol Pharmacol; 2013 Jun; 64(3):331-40. PubMed ID: 23959730
[TBL] [Abstract][Full Text] [Related]
38. The TRPA1 channel in migraine mechanism and treatment.
Benemei S; Fusi C; Trevisan G; Geppetti P
Br J Pharmacol; 2014 May; 171(10):2552-67. PubMed ID: 24206166
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent-Induced Cutaneous Injuries.
Achanta S; Chintagari NR; Balakrishna S; Liu B; Jordt SE
J Pharmacol Exp Ther; 2024 Jan; 388(2):613-623. PubMed ID: 38050077
[TBL] [Abstract][Full Text] [Related]
40. Transient receptor potential ankyrin 1 (TRPA1) channel activation by the thienopyridine-type drugs ticlopidine, clopidogrel, and prasugrel.
Schulze A; Hartung P; Schaefer M; Hill K
Cell Calcium; 2014 Apr; 55(4):200-7. PubMed ID: 24636274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
